Determining the clinical impact of genetic alterations in osteosarcoma
Determining the Clinical Impact of Genetic Alterations in Osteosarcoma
Mesenchymal stem cells (MSCs) and morphogenetic protein (rhBMP-2) associated to ch...
Comparison of the in vitro response between treatments with resveratrol viscum alb...
In vitro expression of cyclooxygenase-2 (COX2) for osteosarcoma exposed to a COX2 ...
Evaluation of in vitro response to treatment with Melittin from Apis mellifera ven...
MiRNAs and mRNA molecular profile of mestatatics and non metastatics osteosarcomas